Biotech European Medicines Agency’s Emergency Task Force Has Initiated the Review of Veru’s Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries August 1, 2022
Biotech Histogen to Report Second Quarter 2022 Financial Results and Provide Business Update August 1, 2022
Biotech Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022 August 1, 2022
Biotech Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma August 1, 2022
Biotech Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call August 1, 2022
Biotech Veru to Report Fiscal 2022 Third Quarter Financial Results, Host Conference Call on August 11th August 1, 2022
Biotech Bionano Genomics to Report Second Quarter 2022 Financial Results and Host a Conference Call and Webcast on August 4, 2022 August 1, 2022
Biotech Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights August 1, 2022